Search Results - "Blamey, RW"

Expression of luminal and basal cytokeratins in human breast carcinoma by Abd El-Rehim, Dalia M, Pinder, Sarah E, Paish, Claire E, Bell, J, Blamey, RW, Robertson, John FR, Nicholson, Robert I, Ellis, Ian O

“…We have examined basal and luminal cell cytokeratin expression in 1944 cases of invasive breast carcinoma, using tissue microarray (TMA) technology, to…”
Get full text

Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity? by Al-Ghazal, SK, Fallowfield, L, Blamey, RW

“…Aims: To investigate any influence of cosmetic outcome on psychosocial morbidity in patients who have undergone breast-conserving surgery for primary breast…”
Get full text

Early-onset breast cancer - histopathological and prognostic considerations by KOLLIAS, J, ELSTON, C. W, ELLIS, I. O, ROBERTSON, J. F. R, BLAMEY, R. W

“…Young age at diagnosis is claimed to be a prognostic factor in the natural history of breast cancer. Of 2879 patients aged < 70 years treated for primary…”
Get full text

High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses by Abd El‐Rehim, Dalia M., Ball, Graham, Pinder, Sarah E., Rakha, Emad, Paish, Claire, Robertson, John F.R., Macmillan, Douglas, Blamey, Roger W., Ellis, Ian O.

“…Recent studies on gene molecular profiling using cDNA microarray in a relatively small series of breast cancer have identified biologically distinct groups…”
Get full text

Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy by ARCHER, S. G, ELIOPOULOS, A, SPANDIDOS, D, BARNES, D, ELLIS, I. O, BLAMEY, R. W, NICHOLSON, R. I, ROBERTSON, J. F. R

“…Several oncogenes and tumour-suppressor genes have been identified that may have an important role in the development of human breast carcinoma. Furthermore,…”
Get full text

Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction by Al-Ghazal, S.K., Fallowfield, L., Blamey, R.W.

“…The aim of this study was to assess and compare the psychological outcome and satisfaction of patients whom underwent wide local excision, mastectomy alone and…”
Get full text

C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators by Travis, A, Pinder, S E, Robertson, J F, Bell, J A, Wencyk, P, Gullick, W J, Nicholson, R I, Poller, D N, Blamey, R W, Elston, C W, Ellis, I O

“…A series of 346 patients with primary operable breast cancer and a series of 145 patients with advanced breast cancer were investigated for c-erbB-3 protein…”
Get full text

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma by ABD EL-REHIM, D. M, PINDER, S. E, PAISH, C. E, BELL, J. A, RAMPAUL, R. S, BLAMEY, R. W, ROBERTSON, J. F. R, NICHOLSON, R. I, ELLIS, I. O

“…The epidermal growth factor receptor (EGFR) family plays an important role in breast carcinogenesis. Much interest has been focused recently on its members…”
Get full text

c-erbB-2 oncoprotein expression in primary and advanced breast cancer by LOVEKIN, C, ELLIS, I. O, LOCKER, A, ROBERTSON, J. F. R, BELL, J, NICHOLSON, R, GULLICK, W. J, ELSTON, C. W, BLAMEY, R. W

“…Immunoreactivity for c-erbB-2 oncogene product expression has been investigated in patients with breast cancer using the polyclonal antibody 21N. Three series…”
Get full text

Combined Tamoxifen and Luteinizing Hormone-Releasing Hormone (LHRH) Agonist Versus LHRH Agonist Alone in Premenopausal Advanced Breast Cancer: A Meta-Analysis of Four Randomized Trials by KLIJN, J. G. M, BLAMEY, R. W, BOCCARDO, F, TOMINAGA, T, DUCHATEAU, L, SYLVESTER, R

“…The logic behind the application of luteinizing hormone-releasing hormone (LHRH) agonists in combination with tamoxifen in premenopausal women is that LHRH…”
Get full text

The psychological impact of immediate rather than delayed breast reconstruction by Al-Ghazal, SK, Sully, L, Fallowfield, L, Blamey, RW

“…Aims: A retrospective analysis of the psychological advantages of immediate reconstruction (IR) against delayed reconstruction (DR). Methods: A total of 121…”
Get full text

Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma by Lee, A.H.S., Pinder, S.E., Macmillan, R.D., Mitchell, M., Ellis, I.O., Elston, C.W., Blamey, R.W.

“…This study aimed to test the hypothesis that lymphovascular invasion adds prognostic information to histological grade and tumour size in node-negative…”
Get full text

Metallothionein expression in human breast cancer by GOULDING, H, JASANI, B, SCHMID, K. W, ELLIS, I. O, PEREIRA, H, REID, A, GALEA, M, BELL, J. A, ELSTON, C. W, ROBERTSON, J. F, BLAMEY, R. W, NICHOLSON, R. A

“…Metallothioneins are ubiquitous low molecular weight proteins characterised by high cysteine content and affinity for binding heavy metals. Abnormal…”
Get full text

Ki67 immunostaining in primary breast cancer: pathological and clinical associations by BOUZUBAR, N, WALKER, K. J, GRIFFITHS, K, ELLIS, I. O, ELSTON, C. W, ROBERTSON, J. F. R, BLAMEY, R. W, NICHOLSON, R. I

“…Ki67 immunostaining has been performed on 136 primary breast cancers and related to various clinical and pathological features of the disease. Staining was…”
Get full text

P2-12-15: GAINS: A Breast Cancer Prognostic Index Utilizing Lymph Node Ratio by Dorairaj, JJ, Wall, D, Newell, J, Blamey, RW, Sweeney, KJ, Ball, G, Kerin, MJ

“…Abstract Introduction: Axillary lymph node status is an important predictor of overall survival (OS), hence its inclusion in clinical prognostic tools. The…”
Get full text

Confirmation of a prognostic index in primary breast cancer by Todd, J H, Dowle, C, Williams, M R, Elston, C W, Ellis, I O, Hinton, C P, Blamey, R W, Haybittle, J L

“…A prognostic index, previously derived in a group of 387 patients with primary breast cancer, has been recalculated for the same patients with over 5 years…”
Get full text

Overexpression of Cyclin D1 Messenger RNA Predicts for Poor Prognosis in Estrogen Receptor-positive Breast Cancer by KENNY, F. S, HUI, R, MUSGROVE, E. A, GEE, J. M. W, BLAMEY, R. W, NICHOLSON, R. I, SUTHERLAND, R. L, ROBERTSON, J. F. R

“…Cyclin D1 is a key cell cycle regulatory protein with demonstrated oncogenic activity in a variety of malignancies. Cyclin D1 mRNA and protein are…”
Get full text

The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women by Robertson, J.F.R., Blamey, R.W.

“…Gonadotrophin-releasing hormone (GnRH) agonists, in particular goserelin (‘Zoladex’), are increasingly being used for the treatment of breast cancer in women…”
Get full text

Neuroendocrine differentiation and prognosis in breast adenocarcinoma by Miremadi, A, Pinder, S E, Lee, A H S, Bell, J A, Paish, E C, Wencyk, P, Elston, C W, Nicholson, R I, Blamey, R W, Robertson, J F, Ellis, I O

“…Neuroendocrine differentiation and prognosis in breast adenocarcinoma Aims: Neuroendocrine differentiation has been detected, and its prognostic value studied,…”
Get full text

The Nottingham Prognostic Index in primary breast cancer by Galea, M H, Blamey, R W, Elston, C E, Ellis, I O

“…In 1982 we constructed a prognostic index for patients with primary, operable breast cancer. This index was based on a retrospective analysis of 9 factors in…”
Get full text